SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-23-003384
Filing Date
2023-03-23
Accepted
2023-03-23 07:05:44
Documents
73
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K mnpr_10k.htm   iXBRL 10-K 1250471
2 DESCRIPTION OF REGISTERED mnpr_ex41.htm EX-4.1 13646
3 LICENSE AGREEMENT mnpr_ex101.htm EX-10.1 28191
4 SUBSIDIARIES OF MONOPAR mnpr_ex211.htm EX-21.1 3847
5 CONSENT OF INDEPENDENT REGISTERED mnpr_ex231.htm EX-23.1 2789
6 CERTIFICATION mnpr_ex311.htm EX-31.1 12594
7 CERTIFICATION mnpr_ex312.htm EX-31.2 12456
8 CERTIFICATION mnpr_ex321.htm EX-32.1 6601
14 mnpr_10kimg15.jpg GRAPHIC 12369
15 mnpr_10kimg13.jpg GRAPHIC 22431
16 mnpr_10kimg12.jpg GRAPHIC 7533
17 mnpr_10kimg1.jpg GRAPHIC 20136
18 mnpr_10kimg16.jpg GRAPHIC 9673
19 mnpr_10kimg17.jpg GRAPHIC 14560
20 mnpr_10kimg18.jpg GRAPHIC 10960
21 mnpr_10kimg3.jpg GRAPHIC 9216
22 mnpr_10kimg4.jpg GRAPHIC 49000
23 mnpr_10kimg8.jpg GRAPHIC 11940
24 mnpr_10kimg14.jpg GRAPHIC 12137
  Complete submission text file 0001654954-23-003384.txt   5067006

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20221231.xsd EX-101.SCH 42665
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20221231_lab.xml EX-101.LAB 266961
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20221231_cal.xml EX-101.CAL 32102
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20221231_pre.xml EX-101.PRE 210811
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20221231_def.xml EX-101.DEF 103577
67 EXTRACTED XBRL INSTANCE DOCUMENT mnpr_10k_htm.xml XML 567093
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39070 | Film No.: 23754441
SIC: 2834 Pharmaceutical Preparations